Zhu X - Search Results

1

Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.

Dai X, Guo Y, Hu Y, Bao X, Zhu X, Fu Q, Zhang H, Tong Z, Liu L, Zheng Y, Zhao P, Fang W. Dai X, et al. Among authors: zhu x. Theranostics. 2021 Jan 19;11(7):3489-3501. doi: 10.7150/thno.54648. eCollection 2021. Theranostics. 2021. PMID: 33537099 Free PMC article. Review.

2

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.

Bao X, Zhang H, Wu W, Cheng S, Dai X, Zhu X, Fu Q, Tong Z, Liu L, Zheng Y, Zhao P, Fang W, Liu F. Bao X, et al. Among authors: zhu x. J Immunother Cancer. 2020 Oct;8(2):e001437. doi: 10.1136/jitc-2020-001437. J Immunother Cancer. 2020. PMID: 33028695 Free PMC article.

3

Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.

Liu L, Zhang R, Deng J, Dai X, Zhu X, Fu Q, Zhang H, Tong Z, Zhao P, Fang W, Zheng Y, Bao X. Liu L, et al. Among authors: zhu x. Cancer Immunol Immunother. 2022 Jan;71(1):121-136. doi: 10.1007/s00262-021-02967-8. Epub 2021 May 24. Cancer Immunol Immunother. 2022. PMID: 34028567 Free PMC article.

4

Efficacy and safety of PD-1 inhibitor combined with antiangiogenic therapy for unresectable hepatocellular carcinoma: A multicenter retrospective study.

Yao J, Zhu X, Wu Z, Wei Q, Cai Y, Zheng Y, Hu X, Hu H, Zhang X, Pan H, Zhong X, Han W. Yao J, et al. Among authors: zhu x. Cancer Med. 2022 Oct;11(19):3612-3622. doi: 10.1002/cam4.4747. Epub 2022 Apr 10. Cancer Med. 2022. PMID: 35403359 Free PMC article.

5

Development and validation of a meta-learning-based multi-modal deep learning algorithm for detection of peritoneal metastasis.

Zhang H, Zhu X, Li B, Dai X, Bao X, Fu Q, Tong Z, Liu L, Zheng Y, Zhao P, Ye L, Chen Z, Fang W, Ruan L, Jin X. Zhang H, et al. Among authors: zhu x. Int J Comput Assist Radiol Surg. 2022 Oct;17(10):1845-1853. doi: 10.1007/s11548-022-02698-w. Epub 2022 Jul 22. Int J Comput Assist Radiol Surg. 2022. PMID: 35867303

6

Oxaliplatin plus irinotecan vs irinotecan as second-line treatment in pancreatic cancer patients: a randomized-controlled open-label Phase II study.

Zhang H, Tong Z, Liu L, Fu Q, Zhu X, Dai X, Bao X, Fang W, Zheng Y, Zhao P. Zhang H, et al. Among authors: zhu x. Gastroenterol Rep (Oxf). 2023 Feb 3;11:goac088. doi: 10.1093/gastro/goac088. eCollection 2023. Gastroenterol Rep (Oxf). 2023. PMID: 36751477 Free PMC article.

7

An immunometabolism subtyping system identifies S100A9⁺ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis.

Bao X, Wang D, Dai X, Liu C, Zhang H, Jin Y, Tong Z, Li B, Tong C, Xin S, Li X, Wang Y, Liu L, Zhu X, Fu Q, Zheng Y, Deng J, Tian W, Guo T, Zhao P, Chen W, Fang W. Bao X, et al. Among authors: zhu x. Cell Rep Med. 2023 Apr 18;4(4):100987. doi: 10.1016/j.xcrm.2023.100987. Epub 2023 Mar 28. Cell Rep Med. 2023. PMID: 36990096 Free PMC article.

8

RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial.

Fu Q, Zheng Y, Fang W, Zhao Q, Zhao P, Liu L, Zhai Y, Tong Z, Zhang H, Lin M, Zhu X, Wang H, Wang Y, Liu Z, Yuan D, Bao X, Gao W, Dai X, Li Z, Liang T. Fu Q, et al. Among authors: zhu x. EClinicalMedicine. 2023 Aug 30;63:102175. doi: 10.1016/j.eclinm.2023.102175. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37680942 Free PMC article.

9

Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study.

Yao J, Wang Z, Sheng J, Wang H, You L, Zhu X, Pan H, Han W. Yao J, et al. Among authors: zhu x. Int Immunopharmacol. 2020 Dec;89(Pt A):107033. doi: 10.1016/j.intimp.2020.107033. Epub 2020 Oct 8. Int Immunopharmacol. 2020. PMID: 33039958

10

Telomeric epigenetic response mediated by Gadd45a regulates stem cell aging and lifespan.

Diao D, Wang H, Li T, Shi Z, Jin X, Sperka T, Zhu X, Zhang M, Yang F, Cong Y, Shen L, Zhan Q, Yan J, Song Z, Ju Z. Diao D, et al. Among authors: zhu x. EMBO Rep. 2018 Oct;19(10):e45494. doi: 10.15252/embr.201745494. Epub 2018 Aug 20. EMBO Rep. 2018. PMID: 30126922 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,047 results

Search Page

Filters